Welcome to our dedicated page for Hillenbrand SEC filings (Ticker: HI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Hillenbrand’s performance means wading through hundreds of pages that span industrial plastics machinery, food-processing systems, and Batesville caskets. Finding segment backlog data or new acquisition disclosures inside a single 10-K is difficult, and insider moves can be buried within separate Form 4s. Stock Titan solves that complexity in seconds.
Our AI reads every Hillenbrand annual report 10-K simplified, each Hillenbrand quarterly earnings report 10-Q filing, and every Hillenbrand 8-K material events explained, then highlights exactly where revenue shifts, order intake, or restructuring charges appear. Need Hillenbrand Form 4 insider transactions real-time? Get instant alerts the moment executives report stock trades. Trying to understand Hillenbrand proxy statement executive compensation before the vote? We translate dense tables into plain English benchmarks.
- Compare APS and MTS margin trends without scanning footnotes.
- Monitor Hillenbrand insider trading Form 4 transactions alongside acquisition updates.
- Review cash-flow impacts from equipment backlogs with one-click Hillenbrand earnings report filing analysis.
Whether you’re assessing durability of plastics demand or verifying Batesville volume guidance, our platform delivers understanding Hillenbrand SEC documents with AI. All filing types update in real time directly from EDGAR, so you never miss a disclosure. Hillenbrand SEC filings explained simply—so you can focus on decisions, not document digging.
On 07/01/2025, Jason Phipps, SVP Global Sales and Marketing of Ciena Corporation (CIEN), filed a Form 4 reporting the sale of 2,325 common shares at $80.50 each, a transaction worth roughly $187 k. The trade was executed under a pre-arranged Rule 10b5-1 plan dated 10/09/2024.
After the sale, Phipps directly owns 84,833 CIEN shares, including unvested RSUs and PSUs. The disposal equals about 2.7 % of his reported holdings, leaving a substantial ownership stake that continues to align management and shareholder interests.
No derivative transactions were disclosed. Given the small size relative to his remaining position and the 10b5-1 framework, the event appears routine with limited market impact for CIEN investors.
Hillenbrand, Inc. (HI) filed a Form 4 indicating that director Neil S. Novich received a total of 731 Restricted Stock Units (RSUs) on 30 June 2025. The RSUs were granted through the company’s deferred stock award program and conversion of deferred director fees, each carrying dividend-equivalent rights and issued at $0 cost. Depending on grant date, the RSUs either vest immediately or on the earlier of the next annual meeting or one year after grant, with share delivery deferred until Mr. Novich leaves the board or upon specific triggering events such as a change in control. No common-stock purchases or sales were reported, so cash flow and share count remain unaffected. Post-grant, the director’s beneficial holdings across award pools range between roughly 2,800 and 6,000 units, underscoring ongoing equity alignment with shareholders.
Hillenbrand, Inc. (HI) filed a Form 4 indicating that director Neil S. Novich received a total of 731 Restricted Stock Units (RSUs) on 30 June 2025. The RSUs were granted through the company’s deferred stock award program and conversion of deferred director fees, each carrying dividend-equivalent rights and issued at $0 cost. Depending on grant date, the RSUs either vest immediately or on the earlier of the next annual meeting or one year after grant, with share delivery deferred until Mr. Novich leaves the board or upon specific triggering events such as a change in control. No common-stock purchases or sales were reported, so cash flow and share count remain unaffected. Post-grant, the director’s beneficial holdings across award pools range between roughly 2,800 and 6,000 units, underscoring ongoing equity alignment with shareholders.
Freshworks Inc. (FRSH) filed a Form 4 disclosing that non-employee director Randy Gottfried received an annual equity grant of 13,236 Class A RSUs on 01-Jul-2025. The award, made under the company’s Non-Employee Director Compensation Policy, carries an exercise/price of $0 and converts 1-for-1 into common shares. The RSUs vest in full on 01-Jul-2026, or earlier should the director fail to be re-elected at the next annual meeting. After the grant Mr. Gottfried’s direct beneficial ownership rises to 53,920 shares. No derivative security transactions were reported. The filing is routine, reflects standard board compensation and results in de-minimis dilution relative to FRSH’s ~300 million shares outstanding.
Form 4 filing for Apollo Global Management, Inc. (APO): Director Mitra O’Neill (professionally known as Mitra Hormozi) reported the grant of 1,446 restricted stock units (RSUs) on 07/01/2025 under the company’s 2019 Omnibus Equity Incentive Plan. Each RSU converts into one share of APO common stock upon vesting, with settlement deferred until the director leaves the board. Following the award, the director’s direct holdings total 30,344 shares (including 7,049 RSUs already held). In addition, 2,500 shares are indirectly held through an entity controlled by the director’s spouse. No shares were sold, no cash changed hands, and no derivative securities were involved. This filing reflects routine, service-based equity compensation aimed at aligning director interests with shareholders rather than signaling a change in company fundamentals.
Form 4 overview � Hillenbrand, Inc. (HI), filed 07/02/2025
Senior Vice President J. Michael Whitted reported multiple equity transactions dated 06/30/2025:
- Restricted-stock unit (RSU) exercise (Code M): 17,989 common shares converted at a $0 exercise price.
- Tax-withholding disposition (Code F): 5,272 shares surrendered at a weighted-average $20.60 (price range $20.27�$20.60).
Resulting direct ownership moved from an implied 68,756 shares pre-exercise to 81,473 shares ±è´Ç²õ³Ù-·É¾±³Ù³ó³ó´Ç±ô»å¾±²Ô²µâ€”a +12,717-share net increase (â‰�+18.5%).
Derivative holdings were also updated. Whitted received or recorded awards under six RSU programs, adding 1, -17,989, 19, 52, 90 and 84 units, leaving:
- 53,954 RSUs from the 6/28/2024 award
- 35,965 RSUs from the same grant after the M conversion
- 1,726; 4,709; 8,153; and 7,630 RSUs under earlier & matching programs
All RSUs carry dividend-equivalent rights and vest in annual tranches through March 31 2028.
Interpretation for investors: No open-market sale occurred aside from statutory tax withholding; the executive’s net equity exposure to HI increased materially. Such exercises are routine around vesting dates but can be viewed as a mild vote of confidence when accompanied by net share accumulation. The transaction size (�$1.6 M based on market price) is not large versus Hillenbrand’s ~$3.5 B market cap and is unlikely to move the stock, yet it modestly strengthens insider-ownership alignment.
Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.� On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.
- Nature of transaction: “A� code denotes acquisition from equity award; “F� code denotes shares withheld for taxes—neither represents an open-market trade.
- Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
- Alignment impact: The executive retains a sizable equity stake (�3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.
Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.
Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.� On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.
- Nature of transaction: “A� code denotes acquisition from equity award; “F� code denotes shares withheld for taxes—neither represents an open-market trade.
- Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
- Alignment impact: The executive retains a sizable equity stake (�3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.
Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.
iShares Bitcoin Trust ETF (ticker IBIT) has filed Pre-Effective Amendment No. 2 to its Post-Effective Amendment No. 2, converting the prior Form S-1 registration to a shelf Form S-3 and updating disclosure through 27 June 2025. The Delaware statutory trust—sponsored by iShares Delaware Trust Sponsor LLC, an indirect subsidiary of BlackRock—issues shares that track the price performance of bitcoin before expenses.
Scale and capital structure. � The Trust’s net asset value (NAV) was $74.20 billion with a per-share NAV of $60.70. � Shares are listed on NASDAQ under the symbol IBIT and trade independently of NAV. � Creation/redemption occurs only in baskets of 40,000 shares, valued at either bitcoin or cash; as of 25 June 2025 one basket equated to 22.72 BTC (� $2.45 million).
Expense profile. The Trust’s single recurring cost is the Sponsor’s Fee of 0.25% (accrued daily, paid quarterly), one of the lowest expense ratios among crypto-linked exchange-traded products. The Sponsor also absorbs a broad range of routine operating expenses—including trustee, administration, audit, listing and registration fees—up to $500 k in annual legal costs, and all organisational costs.
Service framework. � BlackRock Fund Advisors acts as Trustee. � Coinbase Custody Trust Co. is the primary bitcoin custodian; Anchorage Digital Bank N.A. is named as an alternative. � The Bank of New York Mellon serves as cash custodian and administrator. � Prime Execution Agent services are provided by Coinbase Inc.; Cumberland DRW, Flow Traders, JSCT and Virtu are approved bitcoin trading counterparties. � Twelve Authorised Participants can create/redeem in cash; four can transact in-kind.
Key updates. 1) Potential adoption of an in-kind creation/redemption process alongside existing cash flows. 2) Inclusion of audited financial data through the 5 March 2025 annual report. 3) Expanded risk disclosures addressing market volatility, regulatory uncertainty and executive-order developments around a prospective U.S. strategic bitcoin reserve.
Risk highlights. The prospectus devotes extensive space to bitcoin price volatility (one-year trailing volatility � 65%), custody security, fork/air-drop treatment (the Trust permanently abandons ancillary coins), regulatory classification risks under SEC, CFTC, FinCEN and state regimes, and potential divergence between share price and NAV if arbitrage mechanisms are impaired.
Dissolution triggers include delisting, regulatory orders, loss of critical service providers, or failure to qualify as a grantor trust. Upon dissolution, remaining bitcoin would be liquidated and net proceeds distributed via DTC.
Overall, the filing positions IBIT as a large-scale, low-fee vehicle for institutional-grade access to spot bitcoin exposure, while emphasizing the material risks inherent in digital-asset markets.
On 07/01/2025, Gartner Inc. (IT) filed a Form 4 disclosing that outside director Jose M. Gutierrez converted 32 Common Stock Equivalents (CSEs) into an equal number of Gartner common shares at $0 cost. The distribution was made under the company’s Long-Term Incentive Plan (LTIP) and is coded “J,� indicating an ‘other� type of transaction. Immediately before the conversion, Gutierrez received a routine LTIP grant of 32 additional CSEs priced at $406.70 per unit (Code “A�), leaving him with 226 CSEs outstanding after the offsetting distribution.
Following the reported transactions, the director’s direct ownership stands at 1,663 common shares plus the remaining 226 CSEs. The 32-share increase represents an immaterial fraction of Gartner’s ~80 million diluted shares outstanding and does not affect the public float or corporate control. The filing reflects ordinary, compensation-related equity movements rather than a discretionary open-market purchase or sale, and therefore has limited signaling value for investors.